Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc.
Anastasiadou E, Messina E, Sanavia T, Mundo L, Farinella F, Lazzi S, Megiorni F, Ceccarelli S, Pontecorvi P, Marampon F, Di Gioia CRT, Perniola G, Panici PB, Leoncini L, Trivedi P, Lenzi A, Marchese C. Anastasiadou E, et al. Among authors: marchese c. Cells. 2021 Mar 1;10(3):519. doi: 10.3390/cells10030519. Cells. 2021. PMID: 33804458 Free PMC article.
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo.
Anastasiadou E, Seto AG, Beatty X, Hermreck M, Gilles ME, Stroopinsky D, Pinter-Brown LC, Pestano L, Marchese C, Avigan D, Trivedi P, Escolar DM, Jackson AL, Slack FJ. Anastasiadou E, et al. Among authors: marchese c. Clin Cancer Res. 2021 Feb 15;27(4):1139-1149. doi: 10.1158/1078-0432.CCR-20-3139. Epub 2020 Nov 18. Clin Cancer Res. 2021. PMID: 33208342 Free PMC article.
MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms.
Anastasiadou E, Ceccarelli S, Messina E, Gerini G, Megiorni F, Pontecorvi P, Camero S, Onesti MG, Trivedi P, Faenza M, Coscioni E, Nicoletti GF, Napoli C, Marchese C. Anastasiadou E, et al. Among authors: marchese c. PLoS One. 2021 Sep 17;16(9):e0257070. doi: 10.1371/journal.pone.0257070. eCollection 2021. PLoS One. 2021. PMID: 34534238 Free PMC article.
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.
Vescarelli E, Gerini G, Megiorni F, Anastasiadou E, Pontecorvi P, Solito L, De Vitis C, Camero S, Marchetti C, Mancini R, Benedetti Panici P, Dominici C, Romano F, Angeloni A, Marchese C, Ceccarelli S. Vescarelli E, et al. Among authors: marchese c. J Exp Clin Cancer Res. 2020 Jan 2;39(1):3. doi: 10.1186/s13046-019-1490-7. J Exp Clin Cancer Res. 2020. PMID: 31898520 Free PMC article.
When Viruses Cross Developmental Pathways.
Trivedi P, Patel SK, Bellavia D, Messina E, Palermo R, Ceccarelli S, Marchese C, Anastasiadou E, Minter LM, Felli MP. Trivedi P, et al. Among authors: marchese c. Front Cell Dev Biol. 2021 Aug 5;9:691644. doi: 10.3389/fcell.2021.691644. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34422814 Free PMC article. Review.
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma.
Arena A, Romeo MA, Focaccetti C, Anastasiadou E, Trivedi P, Cifaldi L, Gilardini Montani MS, Benedetti R, Santarelli R, Gonnella R, Benvenuto M, Marchese C, Masuelli L, Bei R, Cirone M. Arena A, et al. Among authors: marchese c. Br J Haematol. 2023 Apr;201(2):e12-e15. doi: 10.1111/bjh.18688. Epub 2023 Feb 12. Br J Haematol. 2023. PMID: 36775956 No abstract available.
171 results